Verona Pharma Plc ADR
(VRNA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Operating Expenses | 15,507 | 15,128 | 20,508 | 25,065 | 28,466 |
| Operating Income | -15,049 | -15,128 | -20,508 | -25,065 | -28,466 |
| Interest Expense | 230 | 116 | 91 | 84 | 85 |
| Other Income | 4,856 | -339 | 2,912 | 394 | 5,039 |
| Pre-tax Income | -10,423 | -15,583 | -17,687 | -24,755 | -23,512 |
| Income Tax | 28 | 64 | 79 | 82 | -250 |
| Net Income Continuous | -10,451 | -15,647 | -17,766 | -24,837 | -23,262 |
| Net Income | $-10,451 | $-15,647 | $-17,766 | $-24,837 | $-23,262 |
| EPS Basic Total Ops | -0.09 | -0.23 | -0.32 | -0.40 | -0.30 |
| EPS Basic Continuous Ops | -0.10 | -0.23 | -0.29 | -0.41 | -0.39 |
| EPS Diluted Total Ops | -0.09 | -0.23 | -0.32 | -0.40 | -0.30 |
| EPS Diluted Continuous Ops | -0.10 | -0.23 | -0.29 | -0.41 | -0.39 |
| EBITDA(a) | $-15,276 | $-14,971 | $-20,343 | $-24,902 | $-28,282 |